These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28011067)

  • 1. Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Smeets CC; Kerkhof GF; Hokken-Koelega AC
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):106-116. PubMed ID: 28011067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Kerkhof GF; Smeets CCJ; Hokken-Koelega ACS
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):975-985. PubMed ID: 29102566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Study on Metabolic Health in Adults SGA During 5 Years After GH With or Without 2 Years of GnRHa Treatment.
    Goedegebuure WJ; van der Steen M; Kerkhof GF; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood growth hormone treatment and metabolic and cardiovascular risk in adults born small for gestational age after growth hormone cessation in the Netherlands: a 12-year follow-up study.
    Goedegebuure WJ; van der Steen M; Smeets CCJ; Hokken-Koelega ACS
    Lancet Child Adolesc Health; 2022 Nov; 6(11):777-787. PubMed ID: 36122581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in insulin sensitivity and body composition of small-for-gestational-age adolescents after cessation of growth hormone treatment.
    Willemsen RH; Willemsen SP; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3449-54. PubMed ID: 18559910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fat distribution in short-stature children born small for gestational age.
    Maeyama T; Ida S; Onuma S; Shoji Y; Yamamoto T; Etani Y; Kawai M
    Pediatr Int; 2020 Dec; 62(12):1351-1356. PubMed ID: 32521070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Mineral Density After Cessation of GH Treatment in Young Adults Born SGA: A 5-Year Longitudinal Study.
    Smeets CCJ; van der Steen M; Renes JS; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3508-3516. PubMed ID: 28911145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of GH treatment during childhood on body composition and fat distribution in young adults born SGA.
    Breukhoven PE; Kerkhof GF; van Dijk M; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3710-6. PubMed ID: 21917862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiposity in Children Born Small for Gestational Age Is Associated With β-Cell Function, Genetic Variants for Insulin Resistance, and Response to Growth Hormone Treatment.
    Thankamony A; Jensen RB; O'Connell SM; Day F; Kirk J; Donaldson M; Ivarsson SA; Söder O; Roche E; Hoey H; Ong KK; Dunger DB; Juul A
    J Clin Endocrinol Metab; 2016 Jan; 101(1):131-42. PubMed ID: 26588449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age.
    Sas T; Mulder P; Aanstoot HJ; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):243-51. PubMed ID: 11207640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular filtration rate, blood pressure and microalbuminuria in adults born SGA: A 5-year longitudinal study after cessation of GH treatment.
    Goedegebuure WJ; Kerkhof GF; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):892-898. PubMed ID: 31512772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat mass accumulation during childhood determines insulin sensitivity in early adulthood.
    Leunissen RW; Oosterbeek P; Hol LK; Hellingman AA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Feb; 93(2):445-51. PubMed ID: 18042649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.
    Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age.
    de Kort SW; van Doorn J; van de Sande AG; Leunissen RW; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2010 Feb; 95(2):864-71. PubMed ID: 20061427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity.
    de Zegher F; Ong K; van Helvoirt M; Mohn A; Woods K; Dunger D
    J Clin Endocrinol Metab; 2002 Jan; 87(1):148-51. PubMed ID: 11788639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years.
    Goedegebuure WJ; Van der Steen M; Smeets CCJ; Kerkhof GF; Hokken-Koelega ACS
    Eur J Endocrinol; 2022 May; 187(1):15-26. PubMed ID: 35521698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catch-Up Growth in Children Born Small for Gestational Age Related to Body Composition and Metabolic Risk at Six Years of Age in the UK.
    Marcovecchio ML; Gorman S; Watson LPE; Dunger DB; Beardsall K
    Horm Res Paediatr; 2020; 93(2):119-127. PubMed ID: 32702692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.